IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates USP2. 1 / 1

| 1

reach

"Indeed, in multiple lung cancer cell lines, ML364 reduced the levels of SKP2, as well as MDM2 and Aurora-A, two known substrates of USP2 (23, 31), serving as the positive controls, in a dose- (Fig. 3A) and time-dependent manner (Fig. 3B), which can be completely rescued by MG132 (Fig. 3C)."

34425107

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates USP2. 1 / 1

INDRA sources:

Databases

Reading